Navigation Links
Replidyne to Announce Third Quarter 2007 Earnings
Date:10/9/2007

LOUISVILLE, Colo., Oct. 9 /PRNewswire-FirstCall/ -- Replidyne, Inc. (Nasdaq: RDYN) announced today that it will host a conference call and webcast on Tuesday, October 30, 2007 at 4:45 P.M. EDT to report third quarter 2007 earnings. Callers may participate in the conference call by dialing 800-435-1261 (domestic) or 617-614-4076 (international), and providing the passcode 57078639.

A replay of the conference call will be available approximately one hour after completion of the call through Tuesday, November 13, 2007 at midnight. Callers may access the replay by dialing 888-286-8010 (U.S. participants) or 617-801-6888 (international participants). The audio replay passcode is 69926592. To access a replay of the webcast, visit the Investor Relations section of the company's website at http://www.Replidyne.com.

About Replidyne, Inc.

Replidyne is a biopharmaceutical company focused on discovering, developing, in-licensing and commercializing innovative anti-infective products. Replidyne's lead product, faropenem medoxomil, is a novel oral community antibiotic, expected to be appropriate for use as a first-line antibiotic for treatment of respiratory and skin infections in adult and pediatric patients. Replidyne's second drug candidate, REP8839, is a topical anti-infective product candidate in development for the treatment of skin and wound infections, including methicillin-resistant S. aureus (MRSA) infections. Replidyne's investigational antibacterial agent REP3123 targets Gram-positive C. difficile bacteria and C. difficile-associated disease (CDAD). Replidyne is pursuing the development of other novel anti-infective programs based on its in-house dis
'/>"/>

SOURCE Replidyne, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle, WARF announce partnership to lure stem cell companies
5. Doyle announces $80M renewable energy strategy
6. GE announces first installation of Discovery VCT
7. UWM announces winners of RGI awards
8. Third Wave announces two senior management appointments
9. Mirus announces new method for making antibodies
10. Merge announces sofware updates, upcoming acquisition
11. Small Tree announces ethernet solution for Apple Xserv G5

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)..., DUBLIN,November24/PRNewswire-FirstCall/--Shirep...harmaceuticalcompany,today,announcedthatithassubmi...asealfa,thecompany,senzymereplacementtherapyindeve...sthethirdmarketing,applicationforvelaglucerasealfa...UnitedStatesandCanada. , Basedonaglobalsupply...
(Date:11/24/2009)... Program Connects Customers wi...es Collected with DNA Genotek Products , ...09 -- DNA Genotek , a leading provider of product...and preparation, today announced its new global pa...ncements for DNA Genotek,s partner community and i...
(Date:11/23/2009)...MPAIGN, Ill. You can think of it as origami very...ty of Illinois have developed a technique for fabr...con structures from thin films by coupling photoli...illary interactions. , The films, only a few micr...t possible with thicker pieces of the same materia...
(Date:11/23/2009)..., MISSISSAUGA,ON,Nov.23/PRNewswire-FirstCall/-YMB...sproductdevelopmentcompanythatidentifiesandadvance...satvariousstagesofdevelopment,todayreportedthatCyt...alevaluatingCYT387,apotent,orally-administeredJAK1...cinRochester,Minnesota.AproposaltomergeCytopiainto...
Breaking Biology Technology:Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3Water droplets direct self-assembly process in thin-film materials 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4
..., , , , Company Reports Quarterly Net Income o... International, Inc. (OTC Bulletin Board: CCEL) (...t established family cord blood banks, today annou...28, 2009. Consolidated revenues for the first qua...n compared to approximately $4.2 million for the f...
..., - - Also Announces the expansion of PROVENT(R) S...ONT, Calif., April 9 Ventus Medical, Inc. a priva...sforming the Sleep Disordered Breathing market, to...s President and Chief Executive Officer, effective...urrent CEO Jeffrey Nugent will become Executive Ch...
..., Physicists at the National Institute of Standar...on trap that enables ions to go through an interse...cooler than in prior similar trips, in fact. The d... Physical Review Letters ,* is a step toward scali...um computer using ions (electrically charged atoms...
Other Biology Technology:Cryo-Cell International, Inc. Reports First Quarter 2009 Results 2Cryo-Cell International, Inc. Reports First Quarter 2009 Results 3Cryo-Cell International, Inc. Reports First Quarter 2009 Results 4Ventus Medical Appoints John McCutcheon as President and CEO 2X marks the spot: Ions coldly go through NIST trap junction 2
(Date:11/25/2009)..., Ghrelin, a hormone produced in the stomach, may...lopment of Parkinson,s disease, Yale School of Med... recent issue of the Journal of Neuroscience . ,...of dopamine neurons in an area of the midbrain kno...or dopamine production. Reduced production of dop...
(Date:11/25/2009)..., Over the course of a lifetime, the heart pumps ... In the order to do this, the muscle fibers of the...group headed by Dr. Wolfgang Rottbauer, vice chair...niversity Hospital (Chairman: Prof. Dr. H. A. Katu...or the stability of the smallest muscular unit, th...
(Date:11/24/2009)..., Rocket science is opening new doors to understa...affect the hearing of a marine mammal or if they ...ial sized X-ray scanners that NASA uses to detect ...ockets is now allowing scientists to peek inside t...detailed three-dimensional replicas of a whale,s h...
Breaking Biology News(10 mins):Hormone ghrelin can boost resistance to Parkinson's disease 2New genetic cause of cardiac failure discovered 2Rocket science leads to new whale discovery 2H1N1 Focus of California Hospital Association Disaster Planning Conference 57101 1H1N1 Focus of California Hospital Association Disaster Planning Conference 57101 2H1N1 Focus of California Hospital Association Disaster Planning Conference 57101 3Too Few Latinos Get Colorectal Cancer Tests 57098 1Too Few Latinos Get Colorectal Cancer Tests 57098 2Sage Products Launches Comprehensive Wellness Program with EngagementHealth 28R 29 57094 1Sage Products Launches Comprehensive Wellness Program with EngagementHealth 28R 29 57094 2
...ife in extreme environments research met on March ...bridge (UK) to officially kick off the CAREX proje... life in Extreme Environments). , Life in Extreme ...ich Europe has considerable expertise but a relati...ce of such environments has enormous relevance for...
...s being produced because of viruses infecting micr... today (Wednesday 2 April 2008) at the Society for...is week at the Edinburgh International Conference ...roduced by tiny photosynthesising creatures called...s are also responsible for removing carbon dioxide...
...pril 1, 2008) Identifying genes that are importa...sed to be a monumental task. New technologies and... effective for even the smallest laboratories. Th...( www.cshprotocols.org/TOCs/toc4_08.dtl ) highligh...NU mutagenesis. The method, "Mouse Mutagenesis Us...
Other Biology News:Cold Spring Harbor Protocols features methods to screen genomes and analyze evolution 2
ReBlot Western Blot Recycling Kit - Trial from CHEMICON
ReBlot™ Western Blot Recycling Kit from Upstate
EGTA, Molecular Biology Grade from Research Organics, Inc.
GSD-501 System Calibration Kit from Invitrogen
Biology Products: